May 15, 2012

IDEXX Laboratories' Q1 2012 net income up to US$40.74 million

For the first quarter ended March 31, 2012, IDEXX Laboratories has reported that net income attributable to the stockholders was US$40.74 million, or US$0.72 per diluted share, compared to US$36.61 million, or US$0.62 per diluted share, for the same quarter ended March 31, 2011.

Total revenue for the first quarter ended March 31, 2012 was US$322.68 million, compared to US$292.67 million for the same quarter ended March 31, 2011.

Gross profit for the first quarter ended March 31, 2012 was US$174.77 million, compared to US$154.92 million for the same quarter ended March 31, 2011.

Income from operations for the first quarter ended March 31, 2012 was US$60.41 million, compared to US$53.53 million for the same quarter ended March 31, 2011.

IDEXX Laboratories is a provider of services for the companion animal veterinary, livestock and poultry, water testing and dairy markets.